Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Ganciclovir vs Systemic Acyclovir in Herpetic Keratitis
NCT06757907Completed
- Sponsor
- Al-Azhar University
- Start
- Oct 2024
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised trial of ganciclovir in herpetic keratitis (2 arms), sponsored by Al-Azhar University. Primary endpoint: Corneal healing at 6 weeks. Started Oct 2024; status: completed.
02
Drugs
ganciclovir
03
Conditions
herpetic keratitis
Beyond the preview
Go deeper on NCT06757907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06757907.